These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37977294)

  • 1. Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis.
    Zhang L; Su Y; Shucheng H; Wang L; Jiang X
    J Am Acad Dermatol; 2024 Mar; 90(3):646-648. PubMed ID: 37977294
    [No Abstract]   [Full Text] [Related]  

  • 2. Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.
    Handa S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):634-44. PubMed ID: 21079306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Palmoplantar psoriasis: diagnosis and therapeutic strategy].
    Derancourt C; Van Landuyt H; Laurent R
    Ann Dermatol Venereol; 1998 Mar; 125(3):220-5. PubMed ID: 9747257
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of palmoplantar pustulosis with Tigason.
    Thune P
    Dermatologica; 1982 Jan; 164(1):67-72. PubMed ID: 7040131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response of secukinumab in palmoplantar psoriasis.
    Rocamora V; Garcías-Ladaria J
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles).
    Sánchez-Regaña M; Aldunce Soto MJ; Belinchón Romero I; Ribera Pibernat M; Lafuente-Urrez RF; Carrascosa Carrillo JM; Ferrándiz Foraster C; Puig Sanz L; Daudén Tello E; Vidal Sarró D; Ruiz-Villaverde R; Fonseca Capdevila E; Rodríguez Cerdeira MC; Alsina Gibert MM; Herrera Acosta E; Marrón Moya SE;
    Actas Dermosifiliogr; 2014 Dec; 105(10):923-34. PubMed ID: 24852726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problem sites: scalp, palm and sole, and nail.
    Larko O
    Dermatol Clin; 1995 Oct; 13(4):771-7. PubMed ID: 8785882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of palmoplantar pustular psoriasis with brodalumab.
    Nakao M; Asano Y; Kamata M; Yoshizaki A; Sato S
    Eur J Dermatol; 2018 Aug; 28(4):538-539. PubMed ID: 30129522
    [No Abstract]   [Full Text] [Related]  

  • 9. Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
    Gottlieb A; Sullivan J; van Doorn M; Kubanov A; You R; Parneix A; Hugot S; Milutinovic M
    J Am Acad Dermatol; 2017 Jan; 76(1):70-80. PubMed ID: 27707593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept.
    Weinberg JM
    Cutis; 2003 Nov; 72(5):396-8. PubMed ID: 14655781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V; Guareschi E
    Dermatol Online J; 2010 Jul; 16(7):8. PubMed ID: 20673536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis.
    Prossick TA; Belsito DV
    Cutis; 2006 Sep; 78(3):178-80. PubMed ID: 17036660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open label trial of alefacept in palmoplantar pustular psoriasis.
    Carr D; Tusa MG; Carroll CL; Pearce DJ; Camacho F; Kaur M; Cook C; Willard J; McCarty A; Fleischer AB; Liu CM; Goffe BS; Feldman SR
    J Dermatolog Treat; 2008; 19(2):97-100. PubMed ID: 18512272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmoplantar pustular psoriasis unresponsive to the interleukin-1β antagonist canakinumab.
    Mansouri B; Kivelevitch D; Campa M; Menter A
    Clin Exp Dermatol; 2016 Apr; 41(3):324-6. PubMed ID: 26344848
    [No Abstract]   [Full Text] [Related]  

  • 16. Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis.
    Huang IH; Wu PC; Chiu HY; Huang YH
    Am J Clin Dermatol; 2024 May; 25(3):347-358. PubMed ID: 38438782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study 3--A 41-year-old male with hyperkeratotic changes to the hands and feet.
    Graham-Brown R
    Clin Exp Dermatol; 2011 Mar; 36 Suppl():7. PubMed ID: 21309813
    [No Abstract]   [Full Text] [Related]  

  • 18. Alitretinoin: treatment for refractory palmoplantar keratoderma.
    Park HK; Kim EJ; Ko JY
    Br J Dermatol; 2016 May; 174(5):1143-4. PubMed ID: 26617313
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K; Graff O; Mehta N
    Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fungal infections and nail psoriasis].
    Solovăstru LG; Vâţă D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1083-8. PubMed ID: 20191878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.